| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,252,176 |
|
|
|
Indirect Value
|
$148,061,064 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$149,313,240 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-02-14 |
4 |
AS |
$81.17 |
$7,322,222 |
D/D |
(90,000) |
68,124 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-03-14 |
4 |
OE |
$16.40 |
$1,475,550 |
D/D |
90,000 |
209,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-03-14 |
4 |
AS |
$75.36 |
$6,829,705 |
D/D |
(90,000) |
119,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-04-14 |
4 |
OE |
$16.40 |
$1,475,550 |
D/D |
90,000 |
209,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-04-14 |
4 |
AS |
$66.47 |
$6,032,482 |
D/D |
(90,000) |
119,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-05-14 |
4 |
AS |
$80.24 |
$7,258,752 |
D/D |
(90,000) |
119,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-05-14 |
4 |
OE |
$16.40 |
$1,475,550 |
D/D |
90,000 |
209,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-06-16 |
4 |
OE |
$16.40 |
$1,475,550 |
D/D |
90,000 |
209,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-06-16 |
4 |
AS |
$80.90 |
$7,280,784 |
D/D |
(90,000) |
119,302 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2022-05-17 |
4 |
B |
$3.83 |
$348,529 |
D/D |
90,931 |
303,411 |
2.81 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-10-25 |
4 |
S |
$68.01 |
$6,467,698 |
D/D |
(95,000) |
519,301 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2020-10-14 |
4 |
B |
$19.00 |
$1,814,500 |
I/I |
95,500 |
4,370,496 |
2.66 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2023-11-17 |
4 |
B |
$1.08 |
$106,162 |
D/D |
97,935 |
2,540,665 |
2.81 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-10-25 |
4 |
S |
$47.51 |
$4,765,250 |
D/D |
(100,000) |
505,069 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-05-17 |
4 |
OE |
$16.44 |
$1,643,750 |
D/D |
100,000 |
618,581 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-05-17 |
4 |
S |
$55.55 |
$5,562,700 |
D/D |
(100,000) |
518,581 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-05-21 |
4 |
OE |
$16.01 |
$1,601,000 |
D/D |
100,000 |
1,190,125 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-05-21 |
4 |
S |
$42.61 |
$4,260,880 |
D/D |
(100,000) |
1,090,125 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
174,092 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-08-17 |
4 |
S |
$42.10 |
$4,634,100 |
D/D |
(110,000) |
491,573 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-10-25 |
4 |
OE |
$7.40 |
$839,805 |
D/D |
113,496 |
605,069 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-08-01 |
4 |
S |
$60.43 |
$7,261,322 |
D/D |
(120,000) |
518,581 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-08-01 |
4 |
OE |
$16.44 |
$1,972,500 |
D/D |
120,000 |
638,581 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-05-02 |
4 |
S |
$83.80 |
$10,060,010 |
D/D |
(120,000) |
525,381 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-05-02 |
4 |
OE |
$17.89 |
$2,146,200 |
D/D |
120,000 |
645,381 |
0 |
- |
|
193 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
